Vismodegib dose reduction effective when combined with itraconazole for the treatment of advanced basal cell carcinoma

Vismodegib dose reduction effective when combined with itraconazole for the treatment of advanced basal cell carcinoma

Bibliographic Details
Main Author:	Jaeyoung Yoon, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2021-01-01
Series:	JAAD Case Reports
Subjects:	advanced basal cell carcinoma hedgehog inhibitor itraconazole vismodegib
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512620308092

Similar Items

Complete pathologic clearance with vismodegib in advanced basal cell carcinoma of the scalp with cranial invasion
by: Joseph Dodson, et al.
Published: (2022-12-01)

Treatment of periocular basal cell carcinoma with neoadjuvant vismodegib
by: Maxwell G. Su, et al.
Published: (2020-09-01)

Spotlight on vismodegib in the treatment of basal cell carcinoma: an evidence-based review of its place in therapy
by: Apalla Z, et al.
Published: (2017-05-01)

Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome
by: Glen J. Weiss, et al.
Published: (2011-12-01)

Inhibition of CAL27 Oral Squamous Carcinoma Cell by Targeting Hedgehog Pathway With Vismodegib or Itraconazole
by: Raíza Dias Freitas, et al.
Published: (2020-11-01)

Exploring vismodegib: A non-surgical breakthrough in the management of advanced periocular basal cell carcinoma
by: Georgios Lavasidis, et al.
Published: (2024-01-01)

Vismodegib y sonidegib en el carcinoma de células basales localmente avanzado y metastásico: actualización acerca de los inhibidores de la vía de Hedgehog
by: J. Kurnia Wijaya, et al.
Published: (2022-05-01)

Benefit–risk assessment of sonidegib and vismodegib in the treatment of locally advanced basal cell carcinoma
by: Antonio J García Ruiz, et al.
Published: (2022-07-01)

Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study)
by: Nicolas Bertrand, MD, et al.
Published: (2021-05-01)

Sustained Suppression of Gorlin Syndrome-Associated Basal Cell Carcinomas with Vismodegib or Sonidegib: A Case Series
by: Raquel Wescott, et al.
Published: (2023-10-01)

Granulation tissue masquerading as basal cell carcinoma after treatment with vismodegib
by: Jayson Miedema, MD, et al.
Published: (2018-01-01)

Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test
by: Alessia Villani, et al.
Published: (2019-06-01)

Smoothened receptor inhibitor vismodegib for the treatment of basal cell carcinoma: a retrospective analysis of efficacy and side effects
by: András Bánvölgyi, et al.
Published: (2020-05-01)

The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area
by: Alessia Villani, et al.
Published: (2023-07-01)

A Vismodegib Experience in Elderly Patients with Basal Cell Carcinoma: Case Reports and Review of the Literature
by: Anna Passarelli, et al.
Published: (2020-11-01)

Transformation of facial basal cell carcinoma to squamous cell carcinoma following vismodegib
by: Dustin A. Silverman, et al.
Published: (2021-09-01)

Metastatic same-site squamous cell carcinoma arising during vismodegib therapy for basal cell carcinoma
by: Raymond Zhao, BS, et al.
Published: (2022-10-01)

Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity
by: Massimiliano Scalvenzi, et al.
Published: (2020-04-01)

Basal Cell Carcinoma: A Comprehensive Review
by: Emi Dika, et al.
Published: (2020-08-01)

Hedgehog Pathway Inhibitors and Their Utility in Basal Cell Carcinoma: A Comprehensive Review of Current Evidence
by: Evelyn Yu-Xin Tay, et al.
Published: (2018-12-01)

Activation of AMPK sensitizes medulloblastoma to Vismodegib and overcomes Vismodegib‐resistance
by: Silpa Gampala, et al.
Published: (2021-06-01)

Basal cell cancer treatment. Therapeutic experience with vismodegib therapy
by: N. N. Petenko, et al.
Published: (2018-07-01)

Tailored Toxicity-Driven Administration of Vismodegib in Patients With Multiple or Locally Advanced Basal Cell Carcinoma: A Pilot Analysis
by: Maria Chiara Tronconi, et al.
Published: (2020-11-01)

Gorlin Syndrome: Sequential Digital Dermoscopy of Palpebral Basal Cell Carcinomas in a Patient Treated With Vismodegib
by: Luis Mena-Vergara, et al.
Published: (2022-02-01)

Medical marijuana for the treatment of vismodegib-related muscle spasm
by: Joyce T. Yuan, MD, et al.
Published: (2017-09-01)

Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study
by: Aleksandar Sekulic, et al.
Published: (2017-05-01)

Topical Delivery of Hedgehog Inhibitors: Current Status and Perspectives
by: Kristian Kåber Pedersen, et al.
Published: (2022-11-01)

Vismodegib in PAMAM-dendrimers for potential theragnosis in skin cancer
by: David E. Ybarra, et al.
Published: (2022-07-01)

Arsenic Trioxide, Itraconazole, All-Trans Retinoic Acid and Nicotinamide: A Proof of Concept for Combined Treatments with Hedgehog Inhibitors in Advanced Basal Cell Carcinoma
by: Terenzio Cosio, et al.
Published: (2020-06-01)

[Translated article] Vismodegib and Sonidegib in Locally Advanced and Metastatic Basal Cell Carcinoma: Update on Hedgehog Pathway Inhibitors
by: J. Kurnia Wijaya, et al.
Published: (2022-05-01)

Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis
by: Yuchen Li, et al.
Published: (2019-07-01)

A phase Ib study to assess the efficacy and safety of vismodegib in combination with ruxolitinib in patients with intermediate- or high-risk myelofibrosis
by: Stephen Couban, et al.
Published: (2018-09-01)

Sonidegib for the Treatment of Advanced Basal Cell Carcinoma
by: Gabriella Brancaccio, et al.
Published: (2020-10-01)

Effectiveness, Safety and Utilization of Vismodegib for Locally Advanced Basal Cell Carcinoma Under Real-world Conditions: Non-interventional Cohort Study JONAS
by: Martin Kaatz, et al.
Published: (2022-04-01)

Vismodegib for treatment of periocular basal cell carcinoma – 6-year experience from a tertiary cancer center,
by: Catarina Xavier, et al.
Published: (2022-01-01)

Periocular basal cell carcinoma - clinical perspectives
by: Alena Furdova, et al.
Published: (2020-04-01)

Basal cell nevus syndrome
by: Elizabeth L. Hall, et al.
Published: (2022-06-01)

Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma: A Retrospective Study
by: Florian Herms, et al.
Published: (2022-06-01)

A case of metastatic basal cell carcinoma treated with carboplatin and paclitaxel
by: Chryssoula Papageorgiou, et al.
Published: (2023-01-01)

Experience with sonidegib in patients with advanced basal cell carcinoma: case reports
by: Susana Puig, et al.
Published: (2022-05-01)